Suwon-si, South Korea

Chang Seok Kim



Average Co-Inventor Count = 7.9

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2006-2010

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Chang Seok Kim: Innovator in Humanized Antibody Development

Introduction

Chang Seok Kim is a prominent inventor based in Suwon-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies. With a total of 4 patents to his name, his work has the potential to impact various medical treatments.

Latest Patents

One of his latest patents involves a humanized antibody specific for tumor necrosis factor-alpha. This innovation is prepared from a mouse monoclonal antibody using the complementarity determining region grafting method. The resulting antibodies exhibit an antigen binding affinity similar to the original mouse monoclonal antibody while demonstrating significantly low immunogenicity. This makes them effective for treating diseases related to hTNF-α, such as rheumatoid arthritis, Crohn's disease, and asthma. Another notable patent is a humanized antibody against the S-surface antigen of the hepatitis B virus. This antibody also shows similar antigen-binding affinity to a mouse monoclonal antibody and significantly low immunogenicity, making it useful for treating chronic hepatitis B and preventing HBV infection in patients undergoing liver transplantation.

Career Highlights

Chang Seok Kim is currently associated with Yuhan Corporation, a leading pharmaceutical company in South Korea. His work at Yuhan Corporation has allowed him to focus on innovative solutions in the field of antibody development. His contributions have been instrumental in advancing therapeutic options for various diseases.

Collaborations

Chang Seok Kim has collaborated with notable colleagues, including Tae Hyoung Yoo and Moo Young Song. These collaborations have further enriched his research and development efforts in the biotechnology sector.

Conclusion

Chang Seok Kim's innovative work in humanized antibodies showcases his commitment to advancing medical science. His patents reflect a dedication to improving treatment options for patients with serious health conditions. His contributions to Yuhan Corporation and the field of biotechnology are commendable and highlight the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…